Detalhe da pesquisa
1.
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Mol Ther
; 29(3): 1199-1213, 2021 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212301
2.
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.
Cancer Immunol Immunother
; 69(1): 159-161, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776597
3.
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.
Cancer Immunol Immunother
; 68(8): 1235-1243, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31214732
4.
DeltaPhage--a novel helper phage for high-valence pIX phagemid display.
Nucleic Acids Res
; 40(16): e120, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22539265
5.
Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
Rheumatol Int
; 32(5): 1271-6, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21267570
6.
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors.
Oncoimmunology
; 10(1): 1936757, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34235003
7.
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma.
Blood Adv
; 3(8): 1230-1243, 2019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979721
8.
Phage Display Engineered T Cell Receptors as Tools for the Study of Tumor Peptide-MHC Interactions.
Front Oncol
; 4: 378, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629004
9.
Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4.
Biol Chem
; 390(2): 99-107, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19040354
10.
The N-terminal flanking region of the TRP2360-368 melanoma antigen determines proteasome activator PA28 requirement for epitope liberation.
J Biol Chem
; 282(17): 12749-54, 2007 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17308306